BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design

  April 8, 2026

   · 

  3 min read
• Press Releases

  Ritedose Announces Manufacturing for Tenpoint Therapeutics’ Presbyopia Eye Drop

  April 8, 2026

   · 

  3 min read
• Press Releases

  Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026

  April 8, 2026

   · 

  4 min read
• Press Releases

  Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists

  April 8, 2026

   · 

  2 min read
• Press Releases

  Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference

  April 8, 2026

   · 

  1 min read
• Press Releases

  GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions

  April 8, 2026

   · 

  3 min read
• Press Releases

  RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum

  April 8, 2026

   · 

  9 min read
• Press Releases

  Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients

  April 8, 2026

   · 

  6 min read
• Press Releases

  Shionogi Receives Contract with U.S. Government Through BARDA’s Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats

  April 8, 2026

   · 

  11 min read
• 

  C-suite

  Novavax Shareholder Vows To Fight CEO Pay Package, End ‘Dogmatic Leadership’

  “Your tenure has overseen a DESTRUCTION of shareholder value—a direct result of chronic operational shortcomings and failures on fiduciary duty,” Shah Capital wrote to Novavax’s leadership in an open letter published Wednesday.

  April 8, 2026

   · 

  3 min read

   · 

  Annalee Armstrong